Assertio Holdings (ASRT) Depreciation & Amortization - Total (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Depreciation & Amortization - Total came in at $100000.0 in Q1 2026, little changed year-on-year from $100000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q3 2025.
Assertio Holdings (ASRT) Depreciation & Amortization - Total (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Depreciation & Amortization - Total across 8 years of filings, most recently posting $100000.0 for Q1 2026.
- Depreciation & Amortization - Total for Q1 2026 came in at $100000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $300000.0 (down 25.0% YoY), and the FY2025 annual result was $100000.0, down 50.0% from the prior year.
- Depreciation & Amortization - Total came in at $100000.0 for Q1 2026 at Assertio Holdings, roughly flat from $100000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $200000.0 in Q1 2022 to a low of $100000.0 in Q4 2023.
- The 5-year median for Depreciation & Amortization - Total is $100000.0 (2023), against an average of $143750.0.
- Across the five-year window, Depreciation & Amortization - Total changed 0.0% in 2022 and plunged 50.0% in 2023, its largest moves.
- Assertio Holdings' Depreciation & Amortization - Total stood at $200000.0 in 2022, then slumped by 50.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- The last three Depreciation & Amortization - Total figures came in at $100000.0 (Q1 2026), $100000.0 (Q3 2025), and $100000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |